Briggs Morrison, Director at Syndax Pharmaceuticals Inc (SNDX), sold 52,855 shares at $20.40 ($1.1M) on 2023-07-10, disclosed to the SEC on 2023-07-11.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |
| SNDX | SELL | 2023-05-10 | $2.3M | — | Filing → |